Antibodies

16 Jun 2009 Immunomedics Reports New Antibody for Pretargeted Imaging and Therapy of Colorectal Cancer
16 Jun 2009 Adimab Launches Novel Antibody Discovery Platform and Announces Discovery Programs with Merck and Roche
15 Jun 2009 Immunomedics Reports Updated Phase II Results With Radiolabeled Epratuzumab in Non-Hodgkin's Lymphoma
15 Jun 2009 FibroGen Begins Enrollment of Phase 2 Study of FG-3019, Monoclonal Antibody Against CTGF, in Patients with Diabetic Kidney Disease
12 Jun 2009 ORENCIA® (abatacept) DEMONSTRATES CONSISTENT SAFETY AND EFFECTIVENESS OVER 7 YEARS
11 Jun 2009 Human Genome Sciences reports positive Long-term data for Benlysta(tm) (Formerly Lymphostat-B(R)) in Patients With Active Systemic Lupus Erythematosus
11 Jun 2009 Sanofi-aventis and Regeneron Announce Results from Phase 2 Study with Aflibercept (VEGF Trap) in Advanced Ovarian Cancer Patients with Recurrent Symptomatic Malignant Ascites
11 Jun 2009 ImmunoGen, Inc. Elects to Discontinue Further Internal Development of Its IMGN242 Compound
10 Jun 2009 New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients
10 Jun 2009 New data reinforces long-term efficacy of ACTEMRA in rheumatoid arthritis across all patient population types
10 Jun 2009 RECRUITMENT COMPLETED IN ZALUTUMUMAB HEAD AND NECK CANCER PIVOTAL STUDY
09 Jun 2009 XOMA Presents Data At ADA Demonstrating Improvement in Diabetes and Inflammatory Measures in Animal Model With XOMA 052
09 Jun 2009 Morphotek(R), Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, a Monoclonal Antibody for the Treatment of Solid Tumors
09 Jun 2009 Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
08 Jun 2009 PanGenetics Receives Approval for Clinical Evaluation of Anti-NGF Antibody in Patients with Chronic Pain
08 Jun 2009 Seattle Genetics Reports Data from SGN-35 Every Three Week Dosing Phase I Trial in Lymphoma
08 Jun 2009 Micromet's Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients
08 Jun 2009 Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes
08 Jun 2009 XOMA 052 Clinical Results Support Novel Anti-Inflammatory Approach to Type 2 Diabetes Treatment
07 Jun 2009 New Study Shows Nplate(R) Significantly Reduces Splenectomy Rate and Treatment Failure in Patients With Chronic ITP
05 Jun 2009 Immunomedics Reports Updated Results of Low-Dose Veltuzumab for Immune Thrombocytopenic Purpura
04 Jun 2009 One-year Phase III study confirms Ilaris® offers long-term remission in patients with CAPS, a severe lifelong auto-inflammatory disease
04 Jun 2009 Genmab announces partial clinical hold on Zalutumunab studies
02 Jun 2009 Merck KGaA at Forefront of Exploring Markers of Response in Continued Effort to Personalize Cancer Care
02 Jun 2009 CuraGen Updates CR011-vcMMAE Data at ASCO

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top